BIOQUAL IncAdd to My Watchlist

BIOQ:USOTC USIndustry: Research&Development
  • 42.00
  • 1.00  2.44%
    Today's Change
  • 41.00
    Previous Close
  • Today
    52 Week Low - High
5:20 pm ET 10/23/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding882,592
Market Cap$37 million
Return on Equity ttm9.68%
Last Dividend$0.60
Dividend Yield ttm1.43
Relative Dividend Yield benchmark--
Dividend Ex-Date9/19/17
Dividend Pay Date10/11/17
EPS: Year Actual ttm0.430
EPS: Year Est. -- ttm--
EPS: Quarterly Actual -- 0.94
EPS: Quarterly Est. -- --
Price/Earnings ttm97.67
Relative Price/Earnings4.460
Earnings Growth Rate-68.49
Company Description
BIOQUAL, Inc. specializes in life sciences research involving the utilization of animal models. The Company provides its services to government and commercial contract clients. BIOQUAL conducts research on cancer and other diseases, develops veterinary therapeutics, conducts neurological testing for neurodegenerative disorders, and conducts other research.
Revenue$24 million
Net Income$416,415
Total Assets$5 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!